Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

319.22 -0.94 (-0.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
46 47 Next >
ChemoCentryx Stock More Than Doubles On $4B Buyout
Via Benzinga
Oil Falls Amid Rise In Reserves, China Is Creating A Blockade On Taiwan
Crude oil inventories unexpectedly rose by 4.5 million barrels last week, compared to analysts' forecast of 600,000 barrels. The OPEC+ group said it would raise its oil production target by just... 
Via Talk Markets
Equity Index Futures Rebound Despite Concerns Over OPEC And China
(Wednesday Market Open) Stocks look to rebound as equity index futures point to a higher open and the dollar retreats from yesterday’s rally. But Fed speak and news out of OPEC and China present... 
Via Benzinga
HC Wainwright Is Bullish On DICE Therapeutics - Read Why
Via Benzinga
Don’t Mess With The IRS
If we've learned anything from the likes of Al Capone, it’s that you don’t want to mess with the IRS. That’s especially true when Amgen may be the first target in an aggressive campaign to clamp down... 
Via Talk Markets
10 Highest Yielding Dow Jones Stocks: Which Stocks Pay Out 3.2% To 5.5% To Investors?
Created in 1896 by Charles Dow, the Dow Jones Industrial Average is one of the oldest and most followed equity indexes for overall stock market health. The Dow Jones Industrial Average consists of 30... 
Via Benzinga
U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now
(Tuesday Market Open) Global jitters over U.S. House Speaker Nancy Pelosi’s expected visit to Taiwan dominated premarket trading with major U.S. equities indexes moving mildly lower before the open.... 
Via Benzinga
Is The Energy Ready To Rebound?
(Monday Market Open) Equity index futures turned a bit negative to start a new week and month, as investors are still digesting last week’s data with the S&P 500® index (SPX) near June highs. 
Via Benzinga
Benzinga Before The Bell: Alibaba's Delisting Concerns, Amgen's Potential $10.7B Tax Bill, Kenya Will Not Shut Facebook Services And Other Top Financial Stories Monday, August 1
CNBC 
Via Benzinga
Amgen To Fight IRS Agency Over Tax Bill Of Whooping $10.7B: Report
Via Benzinga
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the... 
Via Benzinga
Big Tech Continues To Rally Despite Earnings Misses
(Friday Market Open) Equity index futures pointed to a higher open as investors looked to wrap up the week and month on a positive note, but a higher-than-expected inflation report pushed the dollar... 
Via Benzinga
Meta and Qualcomm Miss— Will Tech Investors Shrug Off These Reports Too?
(Thursday Market Open) Investors might be ready to take a breather after yesterday’s Fed rate rally, but with slower second-quarter GDP numbers and even more earnings and global economic data arriving... 
Via Benzinga
Should You Buy AbbVie Ahead Of Earnings?
AbbVie (NYSE: ABBV) is due to announce its earnings over the next couple of days. Some investors are considering buying it in advance, but it is worth the investment? 
Via MarketBeat
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 4.3% on an annualized basis producing an average annual return of 11.17%. Currently, Amgen has a market capitalization of... 
Via Benzinga
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
Via Benzinga
Trustworthy Companies Offer Superior Investment Returns With Less Risk
When companies (and the investment community) turn their attention to the long-term benefits of trust, great things happen. 
Via Talk Markets
Dow Jones Giant Amgen Leads 5 Stocks To Watch Near Buy Points
Dow Jones giant Amgen headlines five stocks to watch setting near buy points or key support levels that may offer early entries. 
Via Investor's Business Daily
Dividend Income Update June 2022
Let’s take a look back at my June 2022 dividend income. 
Via Talk Markets
7 Best Pharmaceutical Stocks to Buy Now
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world. 
Via InvestorPlace
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
The group has several commonalities, including strong ratings and promising charts. 
Via Investor's Business Daily
3 Biotech Stocks Outperforming a Bear Market
These biotech stocks are the most attractive from a valuation and growth perspective as they are less impacted by a slowing economy or change in monetary policy. 
Via InvestorPlace
Amgen Touts Early Lumakras Combo Data In KRAS Cancer Settings
BMO Capital Markets says that while Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) + PD1i data was delayed to the August 7 presentation, it did get data on the Lumakras + SHP2 inhibitor combination.  
Via Benzinga
Looking Into Amgen's Recent Short Interest
Amgen's (NASDAQ:AMGN) short percent of float has fallen 6.92% since its last report. The company recently reported that it has 17.22 million shares sold short, which is 3.23% of... 
Via Benzinga
Amgen Whale Trades For July 12
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
The Next CRISPR Is Here: How Verve Plans To Rival Amgen, Regeneron In Cholesterol
This could offer an improvement over CRISPR, which requires cutting DNA. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning Amgen Stock In The Last 10 Years
Amgen (NASDAQ:AMGN) has outperformed the market over the past 10 years by 1.22% on an annualized basis producing an average annual return of 12.18%. Currently, Amgen has a market capitalization of... 
Via Benzinga
Pharma Rally Continues As Pfizer, Amgen Look To Break Out, Pulling Rivals With Them
Four pharmaceutical stocks, including three biotech movers, are making big moves. 
Via Investor's Business Daily
Check Out What Whales Are Doing With AMGN
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Biotech Stocks To Watch And Pharma Industry News
Track the latest trends and leading stocks in the biotech and pharmaceutical industries. 
Via Investor's Business Daily
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
46 47 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.